NCT04688593

Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 520 (estimated)
• Sponsor: Waldemar Link GmbH & Co. KG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results. The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.

Conditions

• Osteoarthritis, Hip
• Hip Osteoarthritis
• Prosthesis Survival
• Prosthesis Failure

Interventions

Type	Name	Description
DEVICE	MobileLink	Patients who receive a MobileLink hip prosthesis system will be followed-up for 10 years.

Timeline

• Start date: 2021-05-04
• Primary completion: 2036-01-01
• Completion: 2036-01-01
• First posted: 2020-12-30
• Last updated: 2024-01-25

Locations

2 sites across 2 countries: Germany, United Kingdom

Regulatory

• FDA-regulated device study